Ikapharmindo Putramas Tbk. (IKPM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Ikapharmindo Putramas Tbk. (IKPM) has a cash flow conversion efficiency ratio of -0.005x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp-1.14 Billion ≈ $-66.85K USD) by net assets (Rp236.96 Billion ≈ $13.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Ikapharmindo Putramas Tbk. fund operations to measure how many days the company can operate on defensive assets alone.
Ikapharmindo Putramas Tbk. - Cash Flow Conversion Efficiency Trend (2022–2024)
This chart illustrates how Ikapharmindo Putramas Tbk.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Ikapharmindo Putramas Tbk. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ikapharmindo Putramas Tbk. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
IVP Limited
NSE:IVP
|
0.067x |
|
Alexium International Group Ltd
AU:AJX
|
0.625x |
|
LL Lucky Games publ AB
ST:LADYLU
|
-0.071x |
|
Millcon Steel Public Company Limited
BK:MILL
|
-0.289x |
|
GR.SOU.COP. LS-01
F:E9E
|
N/A |
|
Austin Gold Corp
NYSE MKT:AUST
|
-0.013x |
|
Genolution Inc.
KQ:225220
|
-0.013x |
|
DOTZ Nano Ltd
AU:DTZ
|
0.228x |
Annual Cash Flow Conversion Efficiency for Ikapharmindo Putramas Tbk. (2022–2024)
The table below shows the annual cash flow conversion efficiency of Ikapharmindo Putramas Tbk. from 2022 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Ikapharmindo Putramas Tbk..
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp246.12 Billion ≈ $14.42 Million |
Rp-33.68 Billion ≈ $-1.97 Million |
-0.137x | -229.09% |
| 2023-12-31 | Rp244.71 Billion ≈ $14.34 Million |
Rp25.94 Billion ≈ $1.52 Million |
0.106x | +399.21% |
| 2022-12-31 | Rp176.70 Billion ≈ $10.35 Million |
Rp3.75 Billion ≈ $219.86K |
0.021x | -- |
About Ikapharmindo Putramas Tbk.
PT Ikapharmindo Putramas Tbk engages in the research and development, manufacturing, and marketing of pharmaceutical products in Indonesia. It operates through three segments: Non Pharma, Pharma, and Contract Manufacturing. The company offers prescription medicines in the areas of neurology, psychiatry, dermatology, nephrology, gastroenterology, cardiology, pulmonology, antibiotics, generics, and… Read more